Kangmei Pharma | 600518 - Debt


Kangmei Pharma reported CNY173.71M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 46.05M 1.46M Dec/2025
Cspc Pharmaceutical CNY 641.11M 146.11M Dec/2025
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Genomma Lab Internacional MXN 7.77B 285.82M Jun/2026
Hypermarcas BRL 8.61B 249.68M Mar/2026
Ionis Pharmaceuticals USD 1.91B 425.5M Jun/2026
IQVIA Holdings USD 16.24B 408M Jun/2026
Jiangsu Hengrui CNY 74.23M 17.2M Dec/2025
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Moderna USD 1.3B 7M Mar/2026
Organon & Co USD 8.57B 75M Mar/2026
Revvity USD 3.35B 48.03M Mar/2026
Sh Fosun Pharma CNY 38.09B 1.1B Dec/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 13.35B 993.3M Jun/2026
Wuxi Apptec CNY 8.38B 41.18M Mar/2026
Xeris Pharmaceuticals USD 258.55M 899K Mar/2026
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026